摘要：SummaryHypoxia is serving crucial roles in cancers. This study aims to comprehensively analyze the molecular features and clinical relevance of a well-defined hypoxia-associated signature in pan-cancer using multi-omics data. Data were acquired from TCGA, CCLE, GDSC, and GEO. RNA expression pattern, copy number variation (CNV), methylation, and mutation of the signature were analyzed. The majority of the 15 genes were upregulated in cancer tissues compared with normal tissue, and RNA expression was negatively associated with methylation level. CNV occurred in almost all the cancers, whereas mutation frequency was low across different cancer types. The signature was also closely related to cancer hallmarks and cancer-related metabolism pathways. NDRG1 was upregulated in kidney cancer tissues as indicated by immunohistochemistry. Besides, most of the 15 genes were risk factors for patients' overall survival. Our results provide a valuable resource that will guide both mechanistic and therapeutic analyses of the hypoxia signature in cancers.Graphical AbstractDisplay OmittedHighlights•Majority of the 15 genes of the hypoxia signature are upregulated in cancers•The signature is closely related to cancer hallmarks and metabolism pathways•CNV is frequent, whereas mutation frequency is low across different cancer types•The 15 genes of the signature are risk factors of overall survivalBiological Sciences; Genomics; Cancer Systems Biology
